Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Validation of the Roche cobas and cobas 4800 Human Papillomavirus Tests on Self-Collected Vaginal Dry Swabs versus Practitioner-Collected Cervical Specimens Using the VALHUDES Protocol.

The Journal of molecular diagnostics : JMD·2026
Same author

Effect of Vitamin D Supplementation on Cardiometabolic Outcomes in Older Australian Adults-Results from the Randomized Controlled D-Health Trial.

Nutrients·2026
Same author

Alcohol consumption and mortality from four alcohol-related cancers in Australia 1950-2018: a time series analysis.

British journal of cancer·2026
Same author

Optimising management of women with HPV (not 16/18): Findings from a national HPV screening program.

Gynecologic oncology·2025
Same author

The Authors Respond.

Epidemiology (Cambridge, Mass.)·2025
Same author

Prediagnostic Exposures and Cancer Survival: Can a Meaningful Causal Estimand Be Specified?

Epidemiology (Cambridge, Mass.)·2025

Related Experiment Video

Updated: Mar 30, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Women's experience with home-based self-sampling for human papillomavirus testing.

Farhana Sultana1, Robyn Mullins2, Dallas R English3,4

  • 1Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia. sultanaf@student.unimelb.edu.au.

BMC Cancer
|November 6, 2015
PubMed
Summary

Human papillomavirus (HPV) self-sampling increases cervical screening participation by overcoming barriers like embarrassment and discomfort. Home-based HPV testing is preferred by most women, though accuracy concerns need addressing.

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

Related Experiment Videos

Last Updated: Mar 30, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

Area of Science:

  • Gynecologic Oncology
  • Public Health
  • Preventive Medicine

Background:

  • Increasing cervical screening coverage is crucial for program effectiveness, especially among inadequately screened populations.
  • Human papillomavirus (HPV) self-sampling offers a strategy to improve screening participation in never or under-screened women.
  • Understanding women's experiences and preferences is key to optimizing HPV self-sampling program participation.

Purpose of the Study:

  • To evaluate the effectiveness of HPV self-sampling in increasing cervical screening participation among never and under-screened women.
  • To explore women's experiences with HPV self-sampling and their preferences for future screening methods.
  • To identify reasons for non-participation in cervical screening and gather suggestions for improvement.

Main Methods:

  • A survey was conducted as part of the 'iPap' trial investigating HPV self-sampling in Victoria, Australia.
  • Questionnaires were mailed to women who participated in self-sampling to assess their experience and preferences.
  • A sample of non-participating women received questionnaires to determine reasons for non-participation and barriers to screening.

Main Results:

  • Common barriers to traditional Pap tests included embarrassment (18%), time constraints (14%), and discomfort (11%).
  • Home-based HPV self-sampling was found to be less embarrassing (94%), uncomfortable (90%), and more convenient (98%).
  • Most women preferred future self-sampling (88%) due to simplicity and avoiding doctor appointments, despite some accuracy concerns (57%).

Conclusions:

  • Home-based HPV self-sampling effectively overcomes emotional and practical barriers, enhancing participation in cervical screening.
  • Addressing women's concerns about test accuracy is important for further optimization of screening programs.
  • Mailing HPV self-sampling kits directly to eligible women can further improve screening uptake.